Diet and Alzheimer’s disease
Authors:
- José A. LuchsingerJLJosé A. Luchsinger
- James M. NobleJNJames M. Noble
- Nikolaos ScarmeasNSNikolaos Scarmeas
- 12 September 2007
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 7 (5) , 366-372
Abstract
Alzheimer’s disease (AD) is increasing in prevalence. There are no known preventive or curative measures. There is evidence that oxidative stress, homocysteinerelated vitamins, fats, and alcohol have a role in the pathogenesis of AD. Some epidemiologic studies suggest that higher dietary intake of antioxidants, vitamins B6, B12, and folate, unsaturated fatty acids, and fish are related to a lower risk of AD, but reports are inconsistent. Modest to moderate alcohol intake, particularly wine, may be related to a lower risk of AD. The Mediterranean diet may also be related to lower AD risk. However, randomized clinical trials of supplements of vitamins E, B12, B6, and folate have shown no cognitive benefit, and randomized trials for other nutrients or diets in AD are not available. The existing evidence does not support the recommendation of specific supplements, foods, or diets for the prevention of AD.Keywords
This publication has 58 references indexed in Scilit:
- Mediterranean diet and risk for Alzheimer's diseaseAnnals of Neurology, 2006
- Modified Mediterranean diet and survival: EPIC-elderly prospective cohort studyBMJ, 2005
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Alzheimer's DiseaseNew England Journal of Medicine, 2004
- Alcohol Intake and Risk of DementiaJournal of the American Geriatrics Society, 2004
- Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's DiseaseNew England Journal of Medicine, 2002
- Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older AdultsStroke, 2001
- Olfactory Deficits in Patients With Mild Cognitive Impairment Predict Alzheimer’s Disease at Follow-UpAmerican Journal of Psychiatry, 2000
- A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's DiseaseNew England Journal of Medicine, 1997
- Alzheimer's Disease--Genotypes, Phenotype, and TreatmentsScience, 1997